Pay in 4 interest-free payments of $7.40 Learn more
Ships within 48 hours · Estimated delivery Nov 5 - Nov 10
These resources are designed to help researchers save time at the study design phase and improve the interpretability of results obtained when using a multi-peptide formulation like the GLOW blend
References About this Article Cite this article Article History DOI Gene Expression eISSN 1555-3884
So, back to the question
Phase 1 dose escalation and expansion study of TROP2 CAR-engineered IL-15-transduced cord blood-derived NK cells in combination with cetuximab in patients with colorectal cancer (CRC) with minimal residual disease (MRD)
& Forman, D
US$ 25.47
US$ 26.89
US$ 26.67
US$ 26.04
US$ 29.38
US$ 29.65
